The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Astellas Pharma; Celgene; Jazz Pharmaceuticals; Menarini; Otsuka; Pfizer; Shire
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Cellectis; Celyad; Daiichi Sankyo; ImmunoGen; Incyte; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Sunesis Pharmaceuticals
Research Funding - Amgen (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Incyte
The impact of infection on health-related quality of life (HRQoL) in patients with Philadelphia negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (Ph- R/R BCP ALL) in a randomized, open-label, phase 3 study (TOWER).
 
Andre C. Schuh
No Relationships to Disclose
 
Yan Li
Employment - Amgen
 
Max S. Topp
Honoraria - Amgen
Consulting or Advisory Role - Affimed Therapeutics; Amgen; Gilead Sciences; Jazz Pharmaceuticals; Regeneron; Roche
Speakers' Bureau - Amgen
Research Funding - Affimed Therapeutics; Amgen; Regeneron; Roche
Patents, Royalties, Other Intellectual Property - Biomarkers for Immunotherapies
Expert Testimony - Affimed Therapeutics; Amgen; Boehringer Ingelheim; Regeneron
Travel, Accommodations, Expenses - Affimed Therapeutics; Amgen; Roche
 
Xinke Zhang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Paul Cannell
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genzyme; Roche
 
Herve Dombret
No Relationships to Disclose
 
Johan Maertens
No Relationships to Disclose
 
Anthony Selwyn Stein
Speakers' Bureau - Amgen; Celgene; Stemline Therapeutics
 
Janet Franklin
Employment - Amgen
Stock and Other Ownership Interests - Amgen